Literature DB >> 27722801

Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND)? An Update on Nomenclature, Pathophysiology and Treatment, and Relationship to Gastroparesis.

Kimberly N Harer1, Pankaj J Pasricha2.   

Abstract

OPINION STATEMENT: Chronic unexplained nausea and vomiting is a debilitating condition that dramatically decreases patient quality of life and creates diagnostic and treatment challenges for healthcare providers. Additionally, the significant overlap in symptoms between disorders such as chronic unexplained nausea and vomiting, gastroparesis, and functional dyspepsia has resulted in a blurring of diagnostic lines and added confusion to the therapeutic approach. The identified overlap in clinical symptoms also suggests a common underlying pathophysiological mechanism may drive these conditions, indicating they could possibly be part of a spectrum of gastric neuromuscular disorders instead of discrete processes. This article will discuss the classification, updates in pathophysiology and therapeutic research, and future directions of research in the treatment of chronic unexplained nausea and vomiting.

Entities:  

Keywords:  Chronic unexplained nausea and vomiting; Gastroparesis; Gastroparesis-like dysfunction; Nausea; Vomiting

Year:  2016        PMID: 27722801      PMCID: PMC5102760          DOI: 10.1007/s11938-016-0113-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  37 in total

1.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Authors:  Nicholas J Talley; G Richard Locke; Yuri A Saito; Ann E Almazar; Ernest P Bouras; Colin W Howden; Brian E Lacy; John K DiBaise; Charlene M Prather; Bincy P Abraham; Hashem B El-Serag; Paul Moayyedi; Linda M Herrick; Lawrence A Szarka; Michael Camilleri; Frank A Hamilton; Cathy D Schleck; Katherine E Tilkes; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

Review 2.  Endoscopic treatment of gastroparesis.

Authors:  Thomas R McCarty; Tarun Rustagi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Authors:  Rudolph M Navari; Rui Qin; Kathryn J Ruddy; Heshan Liu; Steven F Powell; Madhuri Bajaj; Leah Dietrich; David Biggs; Jacqueline M Lafky; Charles L Loprinzi
Journal:  N Engl J Med       Date:  2016-07-14       Impact factor: 91.245

4.  Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting.

Authors:  Timothy R Angeli; Leo K Cheng; Peng Du; Tim Hsu-Han Wang; Cheryl E Bernard; Maria-Giuliana Vannucchi; Maria Simonetta Faussone-Pellegrini; Christopher Lahr; Ryash Vather; John A Windsor; Gianrico Farrugia; Thomas L Abell; Gregory O'Grady
Journal:  Gastroenterology       Date:  2015-04-08       Impact factor: 22.682

5.  Cellular changes in diabetic and idiopathic gastroparesis.

Authors:  Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha
Journal:  Gastroenterology       Date:  2011-02-04       Impact factor: 22.682

6.  Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.

Authors:  Henry P Parkman; Marilyn R Carlson; Dave Gonyer
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-07       Impact factor: 11.382

7.  Gastric peroral endoscopic pyloromyotomy (G-POEM) as a salvage therapy for refractory gastroparesis: a case series of different subtypes.

Authors:  P Mekaroonkamol; L Y Li; S Dacha; Y Xu; S D Keilin; F F Willingham; Q Cai
Journal:  Neurogastroenterol Motil       Date:  2016-05-15       Impact factor: 3.598

8.  Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video).

Authors:  Mouen A Khashab; Sepideh Besharati; Saowanee Ngamruengphong; Vivek Kumbhari; Mohamad El Zein; Ellen M Stein; Alan Tieu; Gerard E Mullin; Sameer Dhalla; Monica C Nandwani; Vikesh Singh; Marcia I Canto; Anthony N Kalloo; John O Clarke
Journal:  Gastrointest Endosc       Date:  2015-08-05       Impact factor: 9.427

9.  Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.

Authors:  J Arts; L Holvoet; P Caenepeel; R Bisschops; D Sifrim; K Verbeke; J Janssens; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2007-11-01       Impact factor: 8.171

10.  Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.

Authors:  Shu-Man Jiang; Lin Jia; Jing Liu; Man-Man Shi; Ming-Zhi Xu
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

View more
  7 in total

Review 1.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

2.  Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?

Authors:  Jonathan Gotfried; Ron Schey
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

3.  Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders.

Authors:  Pankaj J Pasricha; Katherine P Yates; Irene Sarosiek; Richard W McCallum; Thomas L Abell; Kenneth L Koch; Linda Anh B Nguyen; William J Snape; William L Hasler; John O Clarke; Sameer Dhalla; Ellen M Stein; Linda A Lee; Laura A Miriel; Mark L Van Natta; Madhusudan Grover; Gianrico Farrugia; James Tonascia; Frank A Hamilton; Henry P Parkman
Journal:  Gastroenterology       Date:  2017-10-28       Impact factor: 22.682

Review 4.  Abnormalities on Electrogastrography in Nausea and Vomiting Syndromes: A Systematic Review, Meta-Analysis, and Comparison to Other Gastric Disorders.

Authors:  Daniel A Carson; Sameer Bhat; Tommy C L Hayes; Armen A Gharibans; Christopher N Andrews; Gregory O'Grady; Chris Varghese
Journal:  Dig Dis Sci       Date:  2021-05-06       Impact factor: 3.199

5.  Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.

Authors:  Pankaj J Pasricha; Madhusudan Grover; Katherine P Yates; Thomas L Abell; Cheryl E Bernard; Kenneth L Koch; Richard W McCallum; Irene Sarosiek; Braden Kuo; Robert Bulat; Jiande Chen; Robert J Shulman; Linda Lee; James Tonascia; Laura A Miriel; Frank Hamilton; Gianrico Farrugia; Henry P Parkman
Journal:  Gastroenterology       Date:  2021-02-03       Impact factor: 22.682

6.  Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors.

Authors:  Elisabeth K Steinsvik; Jørgen Valeur; Trygve Hausken; Odd H Gilja
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

7.  Standardized system and App for continuous patient symptom logging in gastroduodenal disorders: Design, implementation, and validation.

Authors:  Gabrielle Sebaratnam; Nikita Karulkar; Stefan Calder; Jonathan S T Woodhead; Celia Keane; Daniel A Carson; Chris Varghese; Peng Du; Stephen J Waite; Jan Tack; Christopher N Andrews; Elizabeth Broadbent; Armen A Gharibans; Greg O'Grady
Journal:  Neurogastroenterol Motil       Date:  2022-02-13       Impact factor: 3.960

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.